Vivalink Mobile 6MWT App
Provider 
Founded 2014
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Private, Venture-backed

Mobile application pairing wearable vital-sign monitors with the Six-Minute Walk Test for remote cardiopulmonary assessment.
Vivalink's Mobile 6MWT App digitizes the Six-Minute Walk Test, a standard evaluation of the distance a patient can walk on a flat, hard surface in six minutes. The app works with Vivalink's ultra-small wireless wearable monitors, including a cardiac ECG patch, SpO2 monitor, and wearable blood pressure cuff, and supports live vitals viewing, multi-patient assessment, cloud synchronization, and retrospective analysis.
During the test the wearable monitor captures ECG, heart rate, respiratory rate, oxygen saturation, plethysmography, and blood pressure data. Vivalink's cloud data services provide both raw and filtered data with remote access and clinical integration, and the solution is positioned for cardiac rehabilitation, cardiopulmonary assessment, and clinical trial use, with multi-site consolidation for clinicians.
| Attribute | Vivalink Mobile 6MWT App | BIOS Health: Tracker | |
|---|---|---|---|
| Provider | |||
| Founded | 2014 | 2015 | |
| Sells To | Enterprise | Enterprise | |
| Pricing Model | Recurring, Software | Recurring, Software | |
| Ownership | Private, Venture-backed | Private equity-backed, Venture-backed |
Provider 
Founded 2014
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Private, Venture-backed
Provider 
Founded 2015
Sells To Enterprise
Pricing Model Recurring, Software
Ownership Private equity-backed, Venture-backed


Remote digital walk test letting clinical trial participants perform gait and mobility assessments on an iPhone.


Wearable-sensor endpoint solution capturing gait, balance, and mobility digital endpoints in clinical trials.
Remote digital walk test letting clinical trial participants perform gait and mobility assessments on an iPhone.

Wearable-sensor endpoint solution capturing gait, balance, and mobility digital endpoints in clinical trials.
